The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Open accessAbstract
In a perfect sequence of events, nanoparticles (NPs) are injected into the bloodstream where they circulate until they reach the target tissue. The ligand on the NP surface recognizes its specific receptor expressed on the target tissue and the drug is released in a controlled manner. However, once injected in a physiological environment, NPs interact with biological components and are surrounded by a protein corona (PC). This can trigger an immune response and affect NP toxicity and targeting capabilities. In this review, we provide a survey of recent findings on the NP-PC interactions and discuss how the PC can be used to modulate both cytotoxicity and the immune response as well as to improve the efficacy of targeted delivery of nanocarriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,783
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Mechanisms of Nanoparticle-Induced Oxidative Stress and Toxicity
Manke, A., Wang, L., & Rojanasakul, Y. (2013) · BioMed Research International · doi:10.1155/2013/942916 · Cited by 1,727
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., & Dai, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1468 · Cited by 1,348
Time Evolution of the Nanoparticle Protein Corona
Casals, E., Pfaller, T., Duschl, A., Oostingh, G. J., & Puntes, V. (2010) · ACS Nano · doi:10.1021/nn901372t · Cited by 1,211
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Self-citationKittler, S., Greulich, C., Diendorf, J., Köller, M., & Epple, M. (2010) · Chemistry of Materials · doi:10.1021/cm100023p · Cited by 1,126
Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle
Saptarshi, S. R., Duschl, A., & Lopata, A. L. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-26 · Cited by 1,079
Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,024
Lesniak, A., Fenaroli, F., Monopoli, M. P., Åberg, C., Dawson, K. A., & Salvati, A. (2012) · ACS Nano · doi:10.1021/nn300223w · Cited by 1,020
Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300127-mcp200 · Cited by 1,006
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Binding of blood proteins to carbon nanotubes reduces cytotoxicity
Ge, C., Du, J., Zhao, L., Wang, L., Liu, Y., Li, D., Yang, Y., Zhou, R., Zhao, Y., Chai, Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105270108 · Cited by 940
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation
Deng, Z. J., Liang, M., Monteiro, M., Toth, I., & Minchin, R. F. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2010.250 · Cited by 893
Tenzer, S., Docter, D., Rosfa, S., Wlodarski, A., Kuharev, J., Rekik, A., Knauer, S. K., Bantz, C., Nawroth, T., Bier, C., et al. (2011) · ACS Nano · doi:10.1021/nn201950e · Cited by 856
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
Walkey, C. D., Olsen, J. B., Song, F., Liu, R., Guo, H., Olsen, D. W. H., Cohen, Y., Emili, A., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn406018q · Cited by 815
Surface hydrophobin prevents immune recognition of airborne fungal spores
Aimanianda, V., Bayry, J., Bozza, S., Kniemeyer, O., Perruccio, K., Elluru, S. R., Clavaud, C., Paris, S., Brakhage, A. A., Kaveri, S. V., et al. (2009) · Nature · doi:10.1038/nature08264 · Cited by 792
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700465 · Cited by 777
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
The nanoparticle biomolecule corona: lessons learned – challenge accepted?
Docter, D., Westmeier, D., Markiewicz, M., Stolte, S., Knauer, S. K., & Stauber, R. H. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00217f · Cited by 693
Cancer nanomedicine: from targeted delivery to combination therapy
Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693
Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods
Qiu, Y., Liu, Y., Wang, L., Xu, L., Bai, R., Ji, Y., Wu, X., Zhao, Y., Li, Y., & Chen, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.051 · Cited by 689
Dobrovolskaia, M. A., Patri, A. K., Zheng, J., Clogston, J. D., Ayub, N., Aggarwal, P., Neun, B. W., Hall, J. B., & McNeil, S. E. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.08.001 · Cited by 679
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200700465 · Cited by 655
Rapid translocation of nanoparticles from the lung airspaces to the body
Choi, H. S., Ashitate, Y., Lee, J. H., Kim, S. H., Matsui, A., Insin, N., Bawendi, M. G., Semmler-Behnke, M., Frangioni, J. V., & Tsuda, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1696 · Cited by 648
Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake
Ritz, S., Schöttler, S., Kotman, N., Baier, G., Musyanovych, A., Kuharev, J., Landfester, K., Schild, H., Jahn, O., Tenzer, S., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00108 · Cited by 619
Monteiro-Riviere, N. A., Inman, A. O., & Zhang, L. W. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.030 · Cited by 598
Pozzi, D., Colapicchioni, V., Caracciolo, G., Piovesana, S., Capriotti, A. L., Palchetti, S., De Grossi, S., Riccioli, A., Amenitsch, H., & Laganà, A. (2014) · Nanoscale · doi:10.1039/c3nr05559k · Cited by 581
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Parhi, P., Mohanty, C., & Sahoo, S. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.010 · Cited by 573
Maiorano, G., Sabella, S., Sorce, B., Brunetti, V., Malvindi, M. A., Cingolani, R., & Pompa, P. P. (2010) · ACS Nano · doi:10.1021/nn101557e · Cited by 573
Materials engineering for immunomodulation
Hubbell, J. A., Thomas, S. N., & Swartz, M. A. (2009) · Nature · doi:10.1038/nature08604 · Cited by 561
Robinson, J. T., Welsher, K., Tabakman, S. M., Sherlock, S. P., Wang, H., Luong, R., & Dai, H. (2010) · Nano Research · doi:10.1007/s12274-010-0045-1 · Cited by 525
Milani, S., Baldelli Bombelli, F., Pitek, A. S., Dawson, K. A., & Rädler, J. (2012) · ACS Nano · doi:10.1021/nn204951s · Cited by 496
Targeted nanoparticles for cancer therapy
Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., Langer, R. S., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 478
The long and short of carbon nanotube toxicity
Kostarelos, K. (2008) · Nature Biotechnology · doi:10.1038/nbt0708-774 · Cited by 436
Complement activation and protein adsorption by carbon nanotubes
SALVADORMORALES, C., FLAHAUT, E., SIM, E., SLOAN, J., HGREEN, M., & SIM, R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.02.006 · Cited by 434
Wang, F., Yu, L., Monopoli, M. P., Sandin, P., Mahon, E., Salvati, A., & Dawson, K. A. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.04.010 · Cited by 427
Identification of rapid changes at plasma–solid interfaces
Vroman, L., & Adams, A. L. (1969) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820030106 · Cited by 419
Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids
VROMAN, L. (1962) · Nature · doi:10.1038/196476a0 · Cited by 403
Targeted Nanoparticles for Cancer Therapy
Reddy, G. S. N. (2021) · Journal of Bioanalysis & Biomedicine · Cited by 401
Drug delivery by red blood cells: vascular carriers designed by mother nature
Muzykantov, V. R. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003610633 · Cited by 399
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation
Yang, T., Cui, F.-D., Choi, M.-K., Cho, J.-W., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.011 · Cited by 385
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Hadjidemetriou, M., Al-Ahmady, Z., Mazza, M., Collins, R. F., Dawson, K., & Kostarelos, K. (2015) · ACS Nano · doi:10.1021/acsnano.5b03300 · Cited by 358
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B.-R., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Dos Santos, N., Allen, C., Doppen, A.-M., Anantha, M., Cox, K. A. K., Gallagher, R. C., Karlsson, G., Edwards, K., Kenner, G., Samuels, L., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.12.013 · Cited by 341
Challenges for assessing carbon nanomaterial toxicity to the skin
Monteiro-Riviere, N. A., & Inman, A. O. (2006) · Carbon · doi:10.1016/j.carbon.2005.11.004 · Cited by 339
Differential plasma protein binding to metal oxide nanoparticles
Deng, Z. J., Mortimer, G., Schiller, T., Musumeci, A., Martin, D., & Minchin, R. F. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/45/455101 · Cited by 337
Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid
Dell'Orco, D., Lundqvist, M., Oslakovic, C., Cedervall, T., & Linse, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010949 · Cited by 337
Temperature: The “Ignored” Factor at the NanoBio Interface
Mahmoudi, M., Abdelmonem, A. M., Behzadi, S., Clement, J. H., Dutz, S., Ejtehadi, M. R., Hartmann, R., Kantner, K., Linne, U., Maffre, P., et al. (2013) · ACS Nano · doi:10.1021/nn305337c · Cited by 333
Yan, Y., Gause, K. T., Kamphuis, M. M. J., Ang, C.-S., O’Brien-Simpson, N. M., Lenzo, J. C., Reynolds, E. C., Nice, E. C., & Caruso, F. (2013) · ACS Nano · doi:10.1021/nn404481f · Cited by 322
Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
Huang, B., Abraham, W. D., Zheng, Y., Bustamante López, S. C., Luo, S. S., & Irvine, D. J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5447 · Cited by 312
Personalized protein coronas: a “key” factor at the nanobiointerface
Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F., & Mahmoudi, M. (2014) · Biomaterials Science · doi:10.1039/c4bm00131a · Cited by 307
Nanoparticles for Imaging, Sensing, and Therapeutic Intervention
Bogart, L. K., Pourroy, G., Murphy, C. J., Puntes, V., Pellegrino, T., Rosenblum, D., Peer, D., & Lévy, R. (2014) · ACS Nano · doi:10.1021/nn500962q · Cited by 295
Webb-Robertson, B.-J. M., Wiberg, H. K., Matzke, M. M., Brown, J. N., Wang, J., McDermott, J. E., Smith, R. D., Rodland, K. D., Metz, T. O., Pounds, J. G., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr501138h · Cited by 294
Koren, E., Apte, A., Jani, A., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.002 · Cited by 293
Harashima, H., Sakata, K., Funato, K., & Kiwada, H. (1994) · Pharmaceutical Research · doi:10.1023/a:1018965121222 · Cited by 284
Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform
Toledano Furman, N. E., Lupu-Haber, Y., Bronshtein, T., Kaneti, L., Letko, N., Weinstein, E., Baruch, L., & Machluf, M. (2013) · Nano Letters · doi:10.1021/nl401376w · Cited by 273
Self-citationComplete high‐density lipoproteins in nanoparticle corona
Hellstrand, E., Lynch, I., Andersson, A., Drakenberg, T., Dahlbäck, B., Dawson, K. A., Linse, S., & Cedervall, T. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07062.x · Cited by 272
Yoo, S. I., Yang, M., Brender, J. R., Subramanian, V., Sun, K., Joo, N. E., Jeong, S., Ramamoorthy, A., & Kotov, N. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007824 · Cited by 269
Meeting Report: Hazard Assessment for Nanoparticles—Report from an Interdisciplinary Workshop
Balbus, J. M., Maynard, A. D., Colvin, V. L., Castranova, V., Daston, G. P., Denison, R. A., Dreher, K. L., Goering, P. L., Goldberg, A. M., Kulinowski, K. M., et al. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10327 · Cited by 263
Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide
Hajipour, M. J., Raheb, J., Akhavan, O., Arjmand, S., Mashinchian, O., Rahman, M., Abdolahad, M., Serpooshan, V., Laurent, S., & Mahmoudi, M. (2015) · Nanoscale · doi:10.1039/c5nr00520e · Cited by 256
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity
Khang, D., Lee, Y. K., Choi, E.-J., Webster, T. J., & Kim, S.-H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s72998 · Cited by 244
Safi, M., Courtois, J., Seigneuret, M., Conjeaud, H., & Berret, J.-F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.048 · Cited by 241
Sakulkhu, U., Mahmoudi, M., Maurizi, L., Salaklang, J., & Hofmann, H. (2014) · Scientific Reports · doi:10.1038/srep05020 · Cited by 237
L�ck, M., Paulke, B.-R., Schr�der, W., Blunk, T., & M�ller, R. H. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19980305)39:3<478::aid-jbm19>3.0.co;2-6 · Cited by 225
Casals, E., Pfaller, T., Duschl, A., Oostingh, G. J., & Puntes, V. F. (2011) · Small · doi:10.1002/smll.201101511 · Cited by 225
Secondary Structure of Corona Proteins Determines the Cell Surface Receptors Used by Nanoparticles
Fleischer, C. C., & Payne, C. K. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp502624n · Cited by 225
The “Sweet” Side of the Protein Corona: Effects of Glycosylation on Nanoparticle–Cell Interactions
Wan, S., Kelly, P. M., Mahon, E., Stöckmann, H., Rudd, P. M., Caruso, F., Dawson, K. A., Yan, Y., & Monopoli, M. P. (2015) · ACS Nano · doi:10.1021/nn506060q · Cited by 223
Zhao, Y., Xing, G., & Chai, Z. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.77 · Cited by 220
Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding
Jiang, X., Weise, S., Hafner, M., Röcker, C., Zhang, F., Parak, W. J., & Nienhaus, G. U. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0272.focus · Cited by 212
Silver Nanoparticle Protein Corona Composition in Cell Culture Media
Shannahan, J. H., Lai, X., Ke, P. C., Podila, R., Brown, J. M., & Witzmann, F. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074001 · Cited by 205
Proteases of the complement system
Sim, R. B., & Tsiftsoglou, S. A. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320021 · Cited by 202
The nano-plasma interface: Implications of the protein corona
Wolfram, J., Yang, Y., Shen, J., Moten, A., Chen, C., Shen, H., Ferrari, M., & Zhao, Y. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.02.035 · Cited by 188
Wangoo, N., Suri, C. R., & Shekhawat, G. (2008) · Applied Physics Letters · doi:10.1063/1.2902302 · Cited by 184
Exploiting the Protein Corona around Gold Nanorods for Loading and Triggered Release
Kah, J. C. Y., Chen, J., Zubieta, A., & Hamad-Schifferli, K. (2012) · ACS Nano · doi:10.1021/nn301389c · Cited by 178
Role of reactive oxygen species in cell toxicity
Sies, H., & de Groot, H. (1992) · Toxicology Letters · doi:10.1016/0378-4274(92)90230-h · Cited by 171
Dobrovolskaia, M. A., Neun, B. W., Man, S., Ye, X., Hansen, M., Patri, A. K., Crist, R. M., & McNeil, S. E. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.01.009 · Cited by 169
Toxicity and interaction of titanium dioxide nanoparticles with microtubule protein
Gheshlaghi, Z. N., Riazi, G. H., Ahmadian, S., Ghafari, M., & Mahinpour, R. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/40.9.777 · Cited by 168
Ruge, C. A., Schaefer, U. F., Herrmann, J., Kirch, J., Cañadas, O., Echaide, M., Pérez-Gil, J., Casals, C., Müller, R., & Lehr, C.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040775 · Cited by 165
Sarparanta, M., Bimbo, L. M., Rytkönen, J., Mäkilä, E., Laaksonen, T. J., Laaksonen, P., Nyman, M., Salonen, J., Linder, M. B., Hirvonen, J., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200611d · Cited by 165
Shannahan, J. H., Podila, R., Aldossari, A. A., Emerson, H., Powell, B. A., Ke, P. C., Rao, A. M., & Brown, J. M. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu217 · Cited by 162
Sund, J., Alenius, H. T., Vippola, M., Savolainen, K., & Puustinen, A. (2011) · ACS Nano · doi:10.1021/nn101492k · Cited by 158
Minai, L., Yeheskely‐Hayon, D., & Yelin, D. (2013) · Scientific Reports · doi:10.1038/srep02146 · Cited by 148
Caracciolo, G., Callipo, L., Sanctis, S. C. D., Cavaliere, C., Pozzi, D., & Laganà, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.11.007 · Cited by 145
Ruenraroengsak, P., Novák, P., Berhanu, D., Thorley, A. J., Valsami‐Jones, E., Gorelik, J., Korchev, Y. E., & Tetley, T. D. (2011) · Nanotoxicology · doi:10.3109/17435390.2011.558643 · Cited by 145
Foroozandeh, P., & Aziz, A. A. (2015) · Nanoscale Research Letters · doi:10.1186/s11671-015-0922-3 · Cited by 143
Zhang, H., Burnum-Johnson, K., Luna, M. L., Petritis, B. O., Kim, J., Qian, W., Moore, R., Heredia‐Langner, A., Webb‐Robertson, B., Thrall, B. D., et al. (2011) · PROTEOMICS · doi:10.1002/pmic.201100037 · Cited by 142
Clear and present danger? Engineered nanoparticles and the immune system
Fadeel, B. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13609 · Cited by 137
Comparison of Nanotube–Protein Corona Composition in Cell Culture Media
Shannahan, J. H., Brown, J. M., Chen, R., Ke, P. C., Lai, X., Mitra, S., & Witzmann, F. A. (2013) · Small · doi:10.1002/smll.201202243 · Cited by 135
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A
Ruge, C. A., Kirch, J., Cañadas, O., Schneider, M., Pérez‐Gil, J., Schaefer, U. F., Casals, C., & Lehr, C. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.07.009 · Cited by 134
No King without A Crown – Impact of the Nanomaterial-Protein Corona on Nanobiomedicine
Docter, D., Strieth, S., Westmeier, D., Hayden, O., Gao, M., Knauer, S. K., & Stauber, R. H. (2015) · Nanomedicine · doi:10.2217/nnm.14.184 · Cited by 133
Leroux, J., Jaeghere, F. D., Anner, B. M., Doelker, É., & Gurny, R. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00321-v · Cited by 127
Dai, Q., Yan, Y., Ang, C., Kempe, K., Kamphuis, M. M. J., Dodds, S. J., & Caruso, F. (2015) · ACS Nano · doi:10.1021/nn506929e · Cited by 121
The liposome–protein corona in mice and humans and its implications for in vivo delivery
Caracciolo, G., Pozzi, D., Capriotti, A. L., Cavaliere, C., Piovesana, S., Barbera, G. L., Amici, A. R. D., & Laganà, A. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01316f · Cited by 121
Johnstone, S. A., Masin, D., Mayer, L. D., & Bally, M. B. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00292-9 · Cited by 120
Sakulkhu, U., Maurizi, L., Mahmoudi, M., Motazacker, M. M., de Vries, M., Gramoun, A., Beuzelin, M., Vallée, J., Rezaee, F., & Hofmann, H. (2014) · Nanoscale · doi:10.1039/c4nr02793k · Cited by 117
Crucial Role of the Protein Corona for the Specific Targeting of Nanoparticles
Mahmoudi, M., Sheibani, S., Milani, A. S., Rezaee, F., Gauberti, M., Dinarvand, R., & Vali, H. (2015) · Nanomedicine · doi:10.2217/nnm.14.69 · Cited by 115
Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process
Mirsadeghi, S., Dinarvand, R., Ghahremani, M. H., Hormozi-Nezhad, M. R., Mahmoudi, Z., Hajipour, M. J., Atyabi, F., Ghavami, M., & Mahmoudi, M. (2015) · Nanoscale · doi:10.1039/c4nr06009a · Cited by 114
Evolution of the Protein Corona of Lipid Gene Vectors as a Function of Plasma Concentration
Caracciolo, G., Pozzi, D., Capriotti, A. L., Cavaliere, C., Foglia, P., Amenitsch, H. W., & Laganà, A. (2011) · Langmuir · doi:10.1021/la202912f · Cited by 109
Yin, H. F., Chen, R., Casey, P. S., Ke, P. C., Davis, T. P., & Chen, C. (2015) · RSC Advances · doi:10.1039/c5ra14870g · Cited by 108
Prapainop, K., Witter, D. P., & Wentworth, P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300537u · Cited by 105
Paoli, S. H. D., Diduch, L. L., Tegegn, T. Z., Orečná, M., Strader, M. B., Karnaukhova, E., Bonevich, J. E., Holada, K., & Šimák, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.067 · Cited by 105
Varnamkhasti, B. S., Hosseinzadeh, H., Azhdarzadeh, M., Vafaei, S. Y., Esfandyari‐Manesh, M., Mirzaie, Z. H., Amini, M., Ostad, S. N., Atyabi, F., & Dinarvand, R. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.060 · Cited by 102
Enabling Cytoplasmic Delivery and Organelle Targeting by Surface Modification of Nanocarriers
Parodi, A., Corbo, C., Cevenini, A., Molinaro, R., Palomba, R., Pandolfi, L., Agostini, M., Salvatore, F., & Tasciotti, E. (2015) · Nanomedicine · doi:10.2217/nnm.15.39 · Cited by 102
Self-citationMartel, J., Young, D., Young, A., Wu, C.-Y., Chen, C.-D., Yu, J., & Young, J. D. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.06.018 · Cited by 94
Immune complement activation is attenuated by surface nanotopography
Hulander, M., Lundgren, A., Berglin, Ohrlander, Lausmaa, & Elwing (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24578 · Cited by 90
Surface chemistry and serum type both determine the nanoparticle–protein corona
Pozzi, D., Caracciolo, G., Capriotti, A. L., Cavaliere, C., Barbera, G. L., Anchordoquy, T. J., & Laganà, A. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.02.009 · Cited by 90
Gossmann, R., Fahrländer, E., Hummel, M., Mulac, D., Brockmeyer, J., & Langer, K. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.021 · Cited by 86
A plasma protein corona enhances the biocompatibility of Au@Fe3O4 Janus particles
Landgraf, L., Christner, C., Storck, W., Schick, I., Krumbein, I., Dähring, H., Haedicke, K., Herrmann, K., Teichgräber, U. K.-M., Reichenbach, J. R., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.049 · Cited by 85
Interaction of metal oxide nanoparticles with lung surfactant protein A
Schulze, C., Schaefer, U. F., Ruge, C. A., Wohlleben, W., & Lehr, C. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.10.013 · Cited by 85
Tracking protein corona over time
Lundqvist, M. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.196 · Cited by 84
Yu, K., Lai, B., Foley, J. H., Krisinger, M. J., Conway, E. M., & Kizhakkedathu, J. N. (2014) · ACS Nano · doi:10.1021/nn504186b · Cited by 82
An, S. S. A., Yi, D. K., Ramasamy, M., & Das, M. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s65086 · Cited by 78
Harrison's Principles of Internal Medicine, 14th Edition
Isselbacher, K. J., Wilson, J. D., Martin, J. B., Kasper, D. L., Hauser, S. L., & Longo, D. L. (2012) · Cited by 78
Plasma protein adsorption patterns on liposomes: Establishment of analytical procedure
Diederichs, J. E. (1996) · Electrophoresis · doi:10.1002/elps.1150170332 · Cited by 72
Do plasma proteins distinguish between liposomes of varying charge density?
Capriotti, A. L., Caracciolo, G., Cavaliere, C., Foglia, P., Pozzi, D., Samperi, R., & Laganà, A. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.01.003 · Cited by 71
Kirui, D. K., Celia, C., Molinaro, R., Bansal, S. S., Cosco, D., Fresta, M., Shen, H., & Mauro Ferrari, B. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400738 · Cited by 70
Self-citationTrojan horses and guided missiles: targeted therapies in the war on arthritis
Ferrari, M., Onuoha, S. C., & Pitzalis, C. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.17 · Cited by 69
Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors
Molinaro, R., Wolfram, J., Federico, C., Cilurzo, F., Marzio, L. D., Ventura, C. A., Carafa, M., Celia, C., & Fresta, M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.840286 · Cited by 69
Self-citationBalancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules
Sánchez‐Moreno, P., Buzón, P., Boulaiz, H., Peula-García, J. M., Ortega-Vinuesa, J. L., Luque, I., Salvati, A. L., & Marchal, J. A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.049 · Cited by 57
Choi, S., Lee, J.-A., Kim, M., Kim, H., Lee, J. K., Kim, Y., Oh, J., & Jeong, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79403 · Cited by 54
Cosco, D., Federico, C., Maiuolo, J., Bulotta, S., Molinaro, R., Paolino, D., Tassone, P., & Fresta, M. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s58362 · Cited by 49
Self-citationDobrovolskaia, M. A., & McNeil, S. E. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1042857 · Cited by 46
Blood Interactions with Noble Metals: Coagulation and Immune Complement Activation
Hulander, M., Hong, J., Andersson, M., Gervén, F., Ohrlander, M., Tengvall, P., & Elwing, H. B. (2009) · ACS Applied Materials & Interfaces · doi:10.1021/am900028e · Cited by 45
Capriotti, A. L., Caracciolo, G., Caruso, G., Cavaliere, C., Pozzi, D., Samperi, R., & Laganà, A. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4104-y · Cited by 44
Proteomic Profiling of a Biomimetic Drug Delivery Platform
Corbo, C., Parodi, A., Evangelopoulos, M., Engler, D. A., Matsunami, R. K., Engler, A. C., Molinaro, R., Scaria, S., Salvatore, F., & Tasciotti, E. (2014) · Current Drug Targets · doi:10.2174/1389450115666141109211413 · Cited by 39
Self-citationGray, B. P., McGuire, M. J., & Brown, K. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072938 · Cited by 39
Sobczynski, D. J., Charoenphol, P., Heslinga, M. J., Onyskiw, P. J., Namdee, K., Thompson, A. J., & Eniola‐Adefeso, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107408 · Cited by 39
Capriotti, A. L., Caracciolo, G., Caruso, G., Cavaliere, C., Pozzi, D., Samperi, R., & Laganà, A. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5691-y · Cited by 28
Interview: Nanomedicine: Past, Present and Future
Webster, T. J. (2013) · Nanomedicine · doi:10.2217/nnm.13.37 · Cited by 13
Kumar, A., Forbes, B., Mudway, I., Bicer, E. M., & Dailey, L. A. (2015) · Nanomedicine · doi:10.2217/nnm.15.2 · Cited by 12
Cancer cell targeting of lipid gene vectors by protein corona
Caracciolo, G., Pozzi, D., Capriotti, A. L., Cavaliere, C., Cardarelli, F., Bifone, A., Bardi, G., Salomone, F., & Laganà, A. (2012) · IRIS Research product catalog (Sapienza University of Rome) · Cited by 12
Cited by
Protein corona: a new approach for nanomedicine design
Nguyen, V. H., & Lee, B.-J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 638
Surface Modifications of Nanoparticles for Stability in Biological Fluids
Guerrini, L., Alvarez-Puebla, R. A., & Pazos-Perez, N. (2018) · Materials · doi:10.3390/ma11071154 · Cited by 571
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 571
Carbon Nanotubes: Smart Drug/Gene Delivery Carriers
Zare, H., Ahmadi, S., Ghasemi, A., Ghanbari, M., Rabiee, N., Bagherzadeh, M., Karimi, M., Webster, T. J., Hamblin, M. R., & Mostafavi, E. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s299448 · Cited by 452
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 444
Metadata
- Authors
- Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2015-12-11
- Volume
- 11
- Issue
- 1
- Pages
- 81-100
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2194502287
- Cited by
- 692
- References
- 154
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.